Abstract
Sleep is important for immune function, metabolic function and physical repair. Sleep is more commonly disrupted in women compared with men and is disrupted by surgery, chemotherapy, and cancer itself, making gynecological oncology patients at higher risk of insomnia and sleep disruption. Insomnia and sleep disruption are linked to increased pain, poorer quality of life, depression, and anxiety which can all negatively affect patient outcomes. A number of environmental, behavioral, and pharmacological interventions have been investigated to improve patient sleep and aid in the recovery process. It is vital to understand and address patient sleep quality in order to give patients the highest quality care and improve outcomes.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 669-675 |
| Number of pages | 7 |
| Journal | International Journal of Gynecological Cancer |
| Volume | 32 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 1 2022 |
Funding
Funding ELB is supported by NICHD (K12 HD050121-12), the NIA (P30AG059988-01A1), and the GOG Foundation.
Keywords
- Gynecologic Surgical Procedures
- Ovarian Cancer
- Postoperative Period
- Surgical Oncology
- Uterine Cancer
ASJC Scopus subject areas
- Obstetrics and Gynecology
- Oncology
